A review on the role of carnitine in the management of tamoxifen side effects in treated women with breast cancer

被引：12
|
作者：
El-Ashmawy, Nahla E. [1 ]
Khalil, Rania M. [2 ]
机构：
[1] Tanta Univ, Dept Biochem, Fac Pharm, Tanta, Egypt
[2] Delta Univ, Dept Biochem, Fac Pharm, Gamasah, Egypt
来源：
TUMOR BIOLOGY | 2014年 / 35卷 / 04期
关键词：
Breast cancer; Cancer prognosis; L-carnitine; Resistance; Side effects; Tamoxifen; ACETYL-L-CARNITINE; RANDOMIZED DOUBLE-BLIND; PROPIONYL-L-CARNITINE; FATTY-ACID SYNTHASE; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; OXIDATIVE STRESS; DEPRESSED MOOD; HUMAN CORNEAL; FATIGUE;
D O I：
10.1007/s13277-013-1477-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
l-carnitine is an antioxidant and is found to be a protective agent against many diseases including cancer. This review illustrates the possible role of l-carnitine as an add-on therapy to breast cancer patients maintained on tamoxifen. The objectives of carnitine treatment are diverse: improving tamoxifen-related side effects, offering better cancer prognosis by reducing the risk of developing cancer recurrence or metastasis, and modulating the growth factors which may be, in part, a prospective illustration to overcome tamoxifen resistance. So, it could be recommended to supplement l-carnitine to breast cancer patients starting tamoxifen treatment.
引用
收藏
页码：2845 / 2855
页数：11
相关论文
共 50 条
  • [1] Histeroscopy in women treated with tamoxifen for breast cancer
    Saia, C.
    Leotta, E.
    Cannone, F.
    Militello, M. P.
    Garozzo, V.
    PROCEEDINGS OF THE 1ST AAGL INTERNATIONAL CONGRESS ON MINIMALLY INVASIVE GYNECOLOGY & 4TH SEGI ANNUAL MEETING, 2007, : 205 - 207
  • [2] Tamoxifen decreases breast cancer risk but with side effects
    Reactions Weekly, 2003, 937 (1) : 5 - 5
  • [3] Effects of Tamoxifen on the endometrium of women with breast cancer
    丁颖
    孙爱军
    生殖医学杂志, 2009, 18(S2) (S2) : 90 - 94
  • [4] GYNECOLOGICAL COMPLICATIONS OF WOMEN TREATED WITH TAMOXIFEN FOR BREAST-CANCER
    DEW, JE
    EDEN, JA
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1995, 35 (02): : 198 - 200
  • [5] Profiles of tamoxifen-related side effects by race and smoking status in women with breast cancer
    Zhan, Min
    Flaws, Jodi A.
    Gallicchio, Lisa
    Tkaczuk, Katherine
    Lewis, Lynn M.
    Royak-Schaler, Renee
    CANCER DETECTION AND PREVENTION, 2007, 31 (05): : 384 - 390
  • [6] Ovarian cysts in tamoxifen-treated women with breast cancer
    Inal, MM
    Incebiyik, A
    Sanci, M
    Yildirim, Y
    Polat, M
    Pilanci, B
    Nayki, C
    Camuzcuoglu, H
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 120 (01): : 104 - 106
  • [7] OVARIAN CYSTS IN TAMOXIFEN-TREATED PREMENOPAUSAL WOMEN WITH BREAST-CANCER - A MANAGEMENT DILEMMA
    HOCHNERCELNIKIER, D
    ANTEBY, E
    YAGEL, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (04) : 1323 - 1324
  • [8] ENDOMETRIAL SIDE-EFFECTS WITH TAMOXIFEN FOR BREAST-CANCER
    LEBOUEDEC, G
    DAUPLAT, J
    CURE, H
    ACHARD, JL
    FEILLEL, V
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 169 - 169
  • [9] Side-effects in women treated with adjuvant endocrine therapy for breast cancer
    Rademaker, L. M.
    Gal, R.
    May, A. M.
    Batenburg, M. C. T.
    van der Leij, F.
    Bijlsma, R. M.
    Verkooijen, H. M.
    Doeksen, A.
    Ernst, M. F.
    Evers, D. J.
    van der Pol, C. C.
    Monninkhof, E. M.
    BREAST, 2025, 80
  • [10] Tamoxifen Effects on Cognition and Language in Women with Breast Cancer
    Sharma, Saryu
    Wright, Heather Harris
    SEMINARS IN SPEECH AND LANGUAGE, 2023, 44 (03) : 189 - 202
12345